Amosartan wins Jang Young Sil Award

Hanmi Pharm’s Amorsartan, a combination drug of amlodipine camsylate and losartan potassium, has won IR52 Jang Young Sil Award for its contribution in upgrading the country’s drug technologies and in expanding overseas market share, officials said on September 3.

The Korea Industrial Technology Association selected the Hanmi drug and the award ceremony was held in Seoul.

For the approval,...